Rhinitis
David L. Rosenstreich
<p>Dr. David Rosenstreich is Professor of Medicine, <span id="lw_1270136895_0" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; border-bottom-style: dashed; border-bottom-width: 1px; border-bottom-color: #0066cc; cursor: pointer;">Otolaryngology</span>, and Microbiology and <span id="lw_1270136895_1" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; border-bottom-style: dashed; border-bottom-width: 1px; border-bottom-color: #0066cc; cursor: pointer; background-image: initial; background-attachment: initial; background-origin: initial; background-clip: initial; background-color: transparent; background-position: initial initial; background-repeat: initial initial;">Immunology;</span> Chief of the Division of Allergy and Immunology; and Director of the Bronx <span id="lw_1270136895_2" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; border-bottom-style: dashed; border-bottom-width: 1px; border-bottom-color: #0066cc; cursor: pointer;">Asthma </span>Project. His research currently focuses on the effects of inorganic dietary factors on immune reactivity in humans (specifically, the <span id="lw_1270136895_3" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; cursor: pointer; background-image: initial; background-attachment: initial; background-origin: initial; background-clip: initial; background-color: transparent; border-bottom-style: none; border-bottom-width: initial; border-bottom-color: initial; background-position: initial initial; background-repeat: initial initial;">effects of mercury</span> and acrylamide on human lymphocyte and monocyte production of TH1 and TH2 cytokines in vitro). </p>
<p> </p>
<p>Dr. Rosenstreich completed medical school at <span id="lw_1270136895_4" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial;">NYU School of Medicine</span> and an <span id="lw_1270136895_5" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial;">internal medicine residency</span> at the Bronx Municipal Hospital Center. He spent ten years as an investigator for the National Institutes of Health (NIH), <span id="lw_1270136895_6" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial;">National Institute of Allergy and Infectious Diseases </span>(NIAID) and <span id="lw_1270136895_7" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; cursor: pointer; background-image: initial; background-attachment: initial; background-origin: initial; background-clip: initial; background-color: transparent; border-bottom-style: none; border-bottom-width: initial; border-bottom-color: initial; background-position: initial initial; background-repeat: initial initial;">National Institute of Dental Research</span> (NIDR), and was a visiting professor at the <span id="lw_1270136895_8" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; cursor: pointer; background-image: initial; background-attachment: initial; background-origin: initial; background-clip: initial; background-color: transparent; border-bottom-style: none; border-bottom-width: initial; border-bottom-color: initial; background-position: initial initial; background-repeat: initial initial;">Rockefeller University Laboratory</span> of Cellular Physiology and Immunology. He currently serves on the NIAID/NIH <span id="lw_1270136895_9" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; cursor: pointer; background-image: initial; background-attachment: initial; background-origin: initial; background-clip: initial; background-color: transparent; border-bottom-style: none; border-bottom-width: initial; border-bottom-color: initial; background-position: initial initial; background-repeat: initial initial;">Data Safety Monitoring Board</span>.</p>
<p> </p>
<p><br style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial;" />Dr. Rosenstreich has published over 170 articles, invited papers, and reviews, and has edited three books.</p>
<p><strong>(Partial listing from over 170 research articles, invited papers and reviews and 3 edited books)</strong></p>
<ol>
<li>Rosenstreich, D.L., Lehach, J.G. and Armenaka, M.: Successful management of chronic urticaria. Clin. Rev. Allergy, 1992; 10:371-390.</li>
<li>Armenaka, M. and Rosenstreich, D.L.: The pathophysiology of chronic urticaria. Clin. Rev. Allergy, 1992; 10:257-279.</li>
<li>Small, C.B., Kaufman, A., Armenaka, M.C. and Rosenstreich, D.L.: Sinusitis and atopy in human immunodeficiency virus infection. J. Inf. Dis. 167:283-290, 1993. Armenaka, M., Grizzanti, J.N. and Rosenstreich, D.L.: Serum immunoglobulins and IgG subclass levels in adults with chronic sinusitis: evidence for decreased IgG3 levels. Annals Allergy, 72:507-514; 1994.</li>
<li>Youkeles, L.H., Grizzanti, J.N., Liao, Z., Chang, C.J. and Rosenstreich, D.L.: Decreased tobacco glycoprotein-induced lymphocyte proliferation in vitro in pulmonary eosinophilic granuloma. Am. J. Resp. Crit. Care Med., 151:145-150, 1995.</li>
<li>Ellaurie, M., Rubinstein, A. and Rosenstreich, D.L.: IgE levels in pediatric HIV-infection. Annals Allergy, Asthma, Immunology, 75:332-6, 1995.</li>
<li>Rosenstreich, D.L., Eggleston, P.E., Kattan, M. et. al.: Role of cockroaches in the asthma morbidity of inner-city children. New England J. Medicine, 336:1356-1363; 1997.</li>
<li>De Asis, M.B., Rosenstreich, D.L., Chang, C.J., Gourevitch, M.N., and Small, C.B. Effect of prior hepatitis B infection on serum IgE levels in patients with human immunodeficiency virus infection. Ann Asthma and Immunol, 80:35-8; 1998.</li>
<li>Small, C.B., McGowan, J.P., Klein, R.S., Schnipper, S.M., Chang, C.J, and Rosenstreich, D.L. Serum IgE levels in patients with human immunodeficiency virus infection. Ann All Asthma and Immunol, 81:75-80, 1998.</li>
<li>Eggleston, P.A., Rosenstreich, D., Lynn, H., Gergen, P., Baker, D., Kattan, M., Mortimer, L.M., Mitchell, H., Ownby, D., Slavin, R., Malveaux, F. Relationship of indoor allergen exposure to skin test sensitivity in inner city children with asthma. J. Allergy Clin. Immunol., 102: 563-70, 1998.</li>
<li>Gergen, P.J., Mortimer, K.M., Eggleston, P.A., Rosenstreich, D., Mitchell, H., D., Kattan, M., Baker, D., Wright,E.C., Slavin, R., Malveaux, F. Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes. J. Allergy Clin. Immunol. 103:501-6, 1999</li>
<li>Hudes, G., Vaghjimal, A and Rosenstreich, D.L. Asthma: Diagnosis and Management. in Allergy for Primary Care Physicians, Ed, Altman, Becker and Williams. W.B. Saunders, 2000. </li>
<li>Stevenson, Lori A., P.J. Gergen, D.R. Hoover, D. Rosenstreich, et al Sociodemographic Correlates of Indoor Allergen Sensitivity Among United States Children. J. Allergy Clin. Immunol. 108:747-52, 2001 </li>
<li>Senturia YD. Bauman LJ. Coyle YM. Morgan W. Rosenstreich DL. Roudier MD. Mitchell H. Gruchalla R. Crain EF. The use of parent report to assess the quality of care in primary care visits among children with asthma. Ambulatory Pediatrics. 1:194-200, 2001</li>
<li>Rosenstreich, D.L , Moday, H. and Hudes, G. Asthma and the environment. J. Asthma 40 (Suppl). 23-9, 2003</li>
<li>Hudes, G., Vaghjimal, A and Rosenstreich, D.L. Basic Principles of Allergic Diseases. in Otolaryngology, Basic Science and Clinical Review. Ed. Van de Water and Staeker. Thieme Medical Publishers. 32-43, 2006</li>
<li>Jerschow, El., De Vos, G., Hudes, G., Rubinstein, A., Lipsitz, E., Rosenstreich, D.A Case of Common Variable Immunodeficiency Syndrome Associated With Takayasu Arteritis. Ann All Asthma Immunol. 98:196-9, 2007</li>
<li>de Vos, G. and Rosenstreich, D.L. Immunologic disorders of the larynx. in The Larynx. Ed. M. Fried and A. Ferlito, Plural Publishing. 2007</li>
<li>de Vos, G. S. Abotaga, ZH Liao, E. Jerschow and D. Rosenstreich. Selective effect of mercury on Th2-type cytokine production in humans. Immunopharmacology and Immunotoxicology. 29:537-48, 2007</li>
<li>Jariwala, SP, Fodeman, J., Hudes, G, Ahuja, K, Rosenstreich, D. Functional antibody deficiency in a patient with type I Gaucher disease. J Inherit Metab Dis. 2008 Apr 4. [Epub ahead of print]</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Jariwala%20SP%2522%255BAut… SP</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Moday%20H%2522%255BAuthor%… H</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522de%20Asis%20ML%2522%255BAu… Asis ML</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Fodeman%20J%2522%255BAutho… J</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Hudes%20G%2522%255BAuthor%… G</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522de%20Vos%20G%2522%255BAuth… Vos G</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Rosenstreich%20D%2522%255B… D</a>. The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria. <a>Ann Allergy Asthma Immunol.</a> 102:475-82, 2009</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Fodeman%20J%2522%255BAutho… J</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Jariwala%20S%2522%255BAuth… S</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Hudes%20G%2522%255BAuthor%… G</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Wittner%20M%2522%255BAutho… M</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Klapper%20P%2522%255BAutho… P</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Liu%20Q%2522%255BAuthor%25… Q</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Rosenstreich%20D%2522%255B… D</a>. Scratching the surface. <a>Am J Med.</a> 123:22-6, 2010</li>
</ol>
<p> </p>
<p>David L. Rosenstreich, MD, is Director, Allergy and Immunology and Professor, Medicine at Montefiore Einstein. His clinical focus centers on allergic skin diseases, chronic sinusitis and asthma.</p><p>After obtaining his Bachelor of Science from The City College of New York in 1963, Dr. Rosenstreich earned his Doctor of Medicine from New York University School of Medicine in 1967. He completed his residency in medicine at Einstein in 1969 before becoming a Clinical Associate at the National Institute of Allergy and Infectious Disease, National Institutes of Health until 1971. Dr. Rosenstreich became a Senior Staff Associate until 1972 before moving to the National Institute of Dental Research, National Institutes of Health, where he was Senior Investigator until 1980.</p><p>Building on his clinical focus, Dr. Rosenstreich’s research focuses on the relationship between decreased allergic capacity (immunoglobulin E deficiency) and susceptibility for developing a malignancy. His work has been published in 159 peer-reviewed papers, 64 invited articles and 4 edited books/monographs. Dr. Rosenstreich has been an editor for several scientific journals, such as the <em>Journal of Immunology, Infection</em> and <em>Immunity and Annals of Allergy, Asthma & Immunology</em>.</p><p>Dr. Rosenstreich is board certified by the American Board of Internal Medicine and the American Board of Allergy and Immunology. He is a member of several professional organizations, including the American Association of Physicians, the American Society for Clinical Investigation and the American Academy of Allergy, Asthma and Immunology. Dr. Rosenstreich has won numerous awards for his work, including the Leo M. Davidoff Society for Excellence in Medical Education Award in 2017. He has also been listed in Best Doctors in America, <em>New York Magazine</em> Best Doctors, <em>New York Times</em> Super Doctors, <em>U.S. News & World Report</em> Best Doctors and the Albert Marquis <em>Who’s Who in the World</em> and Lifetime Achievement Award multiple times.</p>
Divya B. Reddy
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><strong><span style="font-size: 12pt; font-family: Calibri;">Education:</span></strong></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;">Dr. Reddy earned her medical degree from Padmashree Dr. D. Y. Patil Medical College, India. She completed a master's degree in clinical epidemiology from Boston University School of Public Health prior to starting her Internal Medicine Residency training at Boston University Medical Center. Her post-graduate training also included a Fellowship in Pulmonary and Critical Care Medicine from Boston University Medical Center with a particular focus on pulmonary infections and associated lung destruction. </span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><strong><span style="font-size: 12pt; font-family: Calibri;">Research Interests:</span></strong></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;">Dr. Reddy has been involved in several patient-oriented research projects in pulmonary infections. As an investigator in the Regional Prospective Observational Research in Tuberculosis (RePORT) cohort in Puducherry and Tamil Nadu, India her work focused on the impact of smoking and biomass fuel use on TB Disease and its treatment outcomes. She is currently developing a database of patients with non-tuberculous mycobacterial infections seen at Montefiore Medical Center in collaboration with the Division of Infectious Diseases. The goal of this project is to better characterize the natural history and clinical outcomes of these infections. She is also involved in the Women’s Interagency HIV Study (WIHS) as the Bronx site pulmonologist and co-investigator to assess the impact of HIV on the development of chronic lung diseases.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;"><strong>Clinical Interests:</strong></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">1. Bronchiectasis </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">2. Tuberculosis</span></p>
<p class="MsoNormal" style="margin: 0in -67.5pt 0.0001pt 0in; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">3. Nontuberculous Mycobacterial (NTM) Infections </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">4. Obstructive lung diseases </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">5. COVID-19</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"> </p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><strong><span style="font-size: 12pt; font-family: Calibri;">Board Certification:</span></strong></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;">Dr. Reddy is board-certified in Internal Medicine, Pulmonary and Critical Care Medicine and is a<span class="apple-converted-space"> </span><span style="border: 1pt none windowtext; padding: 0in;">member of numerous professional societies, including the American Thoracic Society and the Society of Critical Care Medicine.</span></span></p>
Bronchiectasis, Nontuberculous Mycobacterial infections, COPD, Asthma, Interstitial Lung Disease<quillbot-extension-portal></quillbot-extension-portal><quillbot-extension-portal></quillbot-extension-portal>
Bronchiectasis, Nontuberculous mycobacterial infections.<quillbot-extension-portal></quillbot-extension-portal>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; text-align: justify; text-indent: 4.5pt;"><strong><span style="font-family: Calibri;">Original Publications:</span></strong></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; text-align: justify; text-indent: 4.5pt;"><span style="font-family: Calibri;"> </span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">1. <strong>Reddy D</strong>, Little F; Glucocorticoid-Resistant Asthma: More than meets the eye; <em>J Asthma</em> December 2013, Vol. 50, No. 10, Pages 1036-1044, PMID 23923995</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">2. <strong>Reddy D</strong>, O’Donnell MR, Welter-Frost AM, Coe A, Horsburgh CR. Discordance between Tuberculin Skin Test and Interferon Gamma Release Assay is Associated with Previous Latent Tuberculosis Infection Treatment. <em>Mycobact Dis</em> 2016, 6:227. doi: 10.4172/2161-1068.1000227.</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">3. <strong>Divya Reddy</strong>, Jacob Walker, Gary Brandeis MD, Matt Russell MD, C Robert Horsburgh Jr, Natasha Hochberg; Latent Tuberculosis Infection Screening Practices in Long-Term Care Facilities<em>; J Am Geriatr Soc</em>, 2017, 65: 1145–1151. doi:10.1111/jgs.14696, PMID 28467605</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">4. </span><strong style="font-family: Cambria; font-size: 12pt;"><span style="font-family: Calibri;">Divya Reddy</span></strong><span style="font-size: 12pt; font-family: Calibri;">, Yicheng Ma, Subitha Lakshminarayanan, Swaroop Sahu, Laura F. White, Ayiraveetil Reshma, Gautam Roy, Padmini Salgame, Selby Knudsen, Jerrold J. Ellner, C. Robert Horsburgh, Jr., Sonali Sarkar, Natasha S. Hochberg, Severe Undernutrition in Children Affects Tuberculin Skin Test Performance in Southern India. <em>PLoS ONE 16(7): e0250304. https://doi.org/10.1371/journal. pone.0250304, </em></span><span style="font-size: 12pt; font-family: Calibri;">PMID 34270546</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Cambria;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Cambria;"> </p>
<p class="MsoNormal" style="margin: 0in -0.25in 0.0001pt 40.5pt; font-size: medium; font-family: Cambria; text-indent: 4.5pt;"><span style="font-family: Calibri;"> </span></p>
<p class="MsoNormal" style="margin: 0in -0.25in 0.0001pt 40.5pt; font-size: medium; font-family: Cambria; text-indent: -0.5in;"><strong><span style="font-family: Calibri;">Book Chapters:</span></strong></p>
<p class="MsoNormal" style="margin: 0in -0.25in 0.0001pt 40.5pt; font-size: medium; font-family: Cambria; text-indent: 4.5pt;"><span style="font-family: Calibri;"> </span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">1. O’Donnell M, <strong>Reddy D</strong>, Saukkonen J; Antimycobacterial agents; 19<sup>th</sup> Edition of <em>Harrison’s Principles of Internal Medicine</em>, McGraw-Hill Professional, 2015. Volume 2. Chapter 205e, p. 1132-41</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">2. <strong>Reddy D</strong>, O’Donnell M; Antimycobacterial agents; 20<sup>th</sup> Edition of <em>Harrison’s Principles of Internal Medicine, </em>McGraw-Hill Professional, 2018. Volume 1. Chapter 176, p. 1270-79</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">3. <strong>Reddy D</strong>, Saukkonen J; Hepatoxicity associated with anti-tuberculosis treatment;<strong> </strong>3<sup>rd</sup> Edition of <em>Textbook of</em> <em>Tuberculosis and Nontuberculous Mycobacterial Diseases,</em> Jaypee Brothers Medical Publishers, 2019. Chapter 45, p. 637-643</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">4. <strong>Divya Reddy</strong>, Jerrold Ellner; Pathogenesis of Tuberculosis; 6<sup>th </sup>Edition of <em>Clinical Tuberculosis</em>, CRC Press, 2020. Chapter 4, p. 51-76</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri;"> </span></p>
<p>Divya Reddy, MD, MPH, is Program Director, Pulmonary and Critical Care Fellowship and Associate Professor, Medicine at Montefiore Einstein. Her clinical focus centers on bronchiectasis, nontuberculous mycobacterial infections, chronic obstructive pulmonary disease (COPD), asthma and interstitial lung disease.</p><p>After earning her Bachelor of Medicine, Bachelor of Surgery at Dr. D.Y. Patil Medical College in Mumbai, India in 2006, Dr. Reddy moved to the United States to continue her medical training, earning her Master of Public Health at Boston University in 2008. She remained there to complete her internal medicine internship in 2009, followed by her internal medicine residency in 2011. Dr. Reddy then completed a pulmonary and critical care fellowship at Boston University in 2014.</p><p>Building on her clinical experience, Dr. Reddy’s research is focused on bronchiectasis and nontuberculous mycobacterial infections. She has been principal investigator and co-investigator on several funded research projects, and her work has been published in numerous peer-reviewed journals, book chapters, review articles and abstracts. She has also given national and international invited presentations, and is a reviewer for scientific journals including the <em>Journal of American Geriatric Society</em>, <em>Annals of American Thoracic Society</em> and the <em>Journal of Infectious & Non-Infectious Diseases</em>, among others.</p><p>Dr. Reddy is board certified in Pulmonary Medicine and Critical Care Medicine by the American Board of Internal Medicine. She is a member of the American Thoracic Society, the American College of Chest Physicians and the Association of Pulmonary and Critical Care Medicine Program Directors. In 2014 and 2015, Dr. Reddy received the Potts Memorial Foundation Grant award.</p>
Manish Ramesh
<p>Dr. Manish Ramesh was appointed assistant professor in the Einstein/Montefiore Division of Allergy and Immunology in July 2014. He is director of the Montefiore Medical Center Food Allergy Centers in Scarsdale and the Bronx.</p>
<p>Dr. Ramesh completed fellowship training in Allergy and Immunology at the Icahn School of Medicine at Mount Sinai and residency training in internal medicine at Jacobi Medical Center, where he was best overall resident (PGY3) in 2011. He attended medical school in India at S.C.B. Medical College and subsequently obtained his Ph.D. in immunology from University of Connecticut Health Center.</p>
<p>Dr. Ramesh is board certified in Allergy and Immunology and Internal Medicine.</p>
David J. Prezant
<p>Dr. David Prezant is the Chief Medical Officer at the Office of Medical Affairs for the Fire Department of the City of New York (FDNY). Dr. Prezant directs all medical protocol development for both day-to-day operations and homeland security issues. He is also Co-Director of the FDNY World Trade Center Medical Monitoring Program and the Senior Pulmonary Consultant for FDNY.</p>
<p>Dr. Prezant is a member of the Institute of Medicine's Committee on Personal Protective Equipment in the Workplace, the National Fire Protection Association's Health and Safety Committee, and the International Association of Firefighters Redmond Medical Advisory Board. He is a Professor of Medicine at the Albert Einstein College of Medicine; Director of Albert Einstein Medical School's Pulmonary Course for medical students and the Research Director for their Unified Pulmonary Division.</p>
<p>Dr. Prezant responded on 9/11/01 to the World Trade Center and was present during the collapse and its aftermath. Since that day, he and Dr. Kelly (FDNY's Chief Medical Officer at the Bureau of Health Services) have initiated a multi-million dollar medical monitoring and treatment program for FDNY firefighters funded by FDNY, the Centers for Disease Control and Prevention (CDC) and the National Institute for Occupational Safety and Health (NIOSH).</p>
<p>Dr. Prezant is the Principal Investigator for the FDNY Data Coordinating Center for the WTC Medical Monitoring Program and is on the Steering Committee for the WTC Medical Monitoring Program. He served as a member of the EPA WTC Technical Advisory Committee, the NYC Dept of Health WTC Registry Scientific Advisory Board, the NYS Governor's WTC panel and the NYC Mayor's medical advisory board.</p>
<p>Dr. Prezant has written extensively on pulmonary physiology, firefighter health and safety and since 9/11 on the health impact of World Trade Center Collapse on NYC Firefighters and EMS rescue workers. His group was the first to describe WTC Cough Syndrome (New England Journal of Medicine 2002) and has published extensively on this subject in the CDC MMWR, American Journal of Respiratory and Critical Care Medicine, Chest and Environmental Health Perspectives.</p>
<p>His major research interest is in determining the mechanisms responsible for accelerated decline in longitudinal pulmonary function and/or airway hyperreactivity in firefighters after WTC exposure. Other interests are in determining the mechanisms responsible for the increased incidence of sarcoidosis in firefighters after WTC exposure.</p>
<p><strong>Clinical Specialty Areas</strong></p>
<ul>
<li>environmental and occupational lung disease</li>
<li>firefighters respiratory disease</li>
<li>disaster medicine</li>
<li>pulmonary embolism</li>
<li>general pulmonary medicine</li>
</ul>
<p><strong>More</strong></p>
<p><a href="/medicine/pulmonarymedicine/pulmonary_about.aspx?id=14538">Seven Years Later, a Cough and a Covenant</a> (September 10, 2008)</p>
<ol>
<li>World Trade Center site. N Eng J Med 2002;347:806-15.</li>
<li>Banauch GI, McLaughlin M, Hirschhorn R, Corrigan M, Kelly KJ, Prezant DJ. Injuries and Illnesses among New York City Fire Department rescue workers after responding to the World Trade Center Attacks. MMWR 2002;51:1-5.</li>
<li>Prezant DJ, Kelly KJ, Jackson B, Peterson D, Feldman D, Baron S, Mueller CA, Bernard B, Lushniak B, Smith L, BerryAnn R, Hoffman B. Use of respiratory protection among responders at the World Trade Center Site, New York City, September 2001. MMWR 2002;51:6-8.</li>
<li>Rom WN, Weiden M, Garcia R, Ting AY, Vathesatogkit P, Tse DB, McGuinness G, Roggli V, Prezant DJ. Acute eosinophilic pneumonia in a New York City firefighter exposed to world trade center dust. Am. J. Resp. Crit. Care Med. 2002;166:797-800.</li>
<li>Banauch GI, Alleyne D, Sanchez R, Olender K, Weiden M, Kelly KJ, and PREZANT DJ. Persistent bronchial hyperreactivity in New York City firefighters and rescue workers following collapse of World Trade Center. Am. J. Resp. Crit. Care Med. 2003; 168:54-62.</li>
<li>Edelman P, Osterloh J, Pirkle J, Grainger J, Jones R, Blount B, Calafat A, Turner W, Caudill S, Feldman DM, Baron S, Bernard BP, Lushniak BD, Kelly KJ, PREZANT DJ. Biomonitoring of chemical exposure among New York City firefighters responding to the World Trade Center fire and collapse. Environ Health Perspect, 2003; 111:1906-1911.</li>
<li>Feldman DM, Baron S, Mueller CA, Bernard BP, Lushniak BD, Kelly KJ, PREZANT DJ. Initial symptoms, respiratory function and respirator use in New York City firefighters responding to the World Trade Center (WTC) disaster. Chest 2004;125:1256-64.</li>
<li>World Trade Center dust. Environ Health Perspect, 2004; 112:1564-1569.</li>
<li>Banauch GI, Dhala A, Alleyne D, Alva R, Santhyadka G, Krasko A, Weiden M, Kelly KJ, Prezant DJ. Bronchial hyperreactivity and other inhalation lung injuries in rescue/recovery workers after the World Trade Center collapse. Crit Care Med. 2005;33:S102-S106.</li>
<li>World Trade Center site. Curr Opin Pulm Med 2005; 11:160-8.</li>
<li>Paul Greene, Dianne Kane, Grace Christ, Sallie Lynch and Malachy Corrigan. FDNY crisis counseling: innovative responses to 9/11 firefighters, families, and communities. Published 2005.A textbook in counseling at FDNY after WTC.</li>
<li>Bars MP, Banauch GI, Appel DW, Andreaci M, Mouren P, Kelly KJ, Prezant DJ. Tobacco Free with FDNY: The New York City Fire Department World Trade Center Tobacco Cessation Study. Chest 2006; 129:979-987.</li>
<li>World Trade Center exposure in the New York City Fire Department. Am. J. Respir. Crit. Care Med. 2006; 174:312-319.</li>
<li>Friedman S, Cone J, Eros-Sarnyai M, Prezant D,m Szeinuk J, Clark N, Milek D, Levin S, Gillio R. Clinical guidelines for adults exposed to World Trade Center Disaster (Respiratory and Mental Health). City Health Info (CHI), NYC Department of Health and Mental Hygiene. September 2006</li>
<li>Lioy PJ, Pellizzari E, and Prezant DJ. Understanding and learning from the WTC Aftermath and its affect on health through Human Exposure Science. Environ. Science Technology. November 15, 2006 ; 6876-6885.</li>
<li>Izbicki G, Chavko R, Banauch GI, Weiden M, Berger K, Kelly KJ, Aldrich TK and Prezant DJ. World Trade Center Sarcoid-like Granulomatous Pulmonary Disease in New York City Fire Department Rescue Workers. CHEST (In press)</li>
<li>Izbicki G, Chavko R, Banauch GI, Weiden M, Berger K, Kelly KJ, Hall C, Aldrich TK and Prezant DJ.  World Trade Center Sarcoid-like Granulomatous Pulmonary Disease in New York City Fire Department Rescue Workers.  Chest, 2007;131:1414-1423</li>
<li>Weiden M, Banauch G, Kelly KJ, and Prezant DJ. Environmental and Occupational Medicine. Firefighters Health and Health Effects of the World Trade Center Collapse. Pgs 477-490. 4th Edition, Edited by Rom WN and Markowitz S. Lippincott-Raven Inc. Philadelphia, 2007.</li>
<li>Alvarez J, Rosen C, Davis K, Smith G, Corrigan M. Stay Connected : psychological services for retired firefighters after 11 September 2001.  PreHospital Disaster Med. 2007 ;22 :49-54.</li>
<li>Menendez AM, Molloy J., Magaldi MC. Health responses of New York City firefighter spouses and their families post-September 11, 2001 terrorist attacks.  Issues Ment Health Nurs. 2006; 27:905-17.</li>
<li>Kelly KJ, Niles J, McLaughlin MT, Carrol S, Corrigan M, Al-Othman F, and Prezant DJ.  World Trade Center health Impacts on FDNY Rescue Workers - a six year assessment, September 2001 to 2007.  Fire Department of the City of New York, October 2007. Available on-line at: <a href="http://www.nyc.gov/html/om/pdf/2007/wtc_health_impacts_on_fdny_rescue_w…; target="_blank">http://www.nyc.gov/html/om/pdf/2007/wtc_health_impacts_on_fdny_rescue_w…;
<li>Prezant DJ. WTC Cough Syndrome and its Treatment. Lung. 2008 ; 186 :94S-102S.</li>
<li>Banauch GI, Izbicki G, Chavko R, Christodoulou V, Weiden MD, Webber MP, Cohen HW, Gustave J, Aldrich TK, Kelly KJ, and Prezant DJ. Trial of Prophylactic Inhaled Steroids to Prevent or Reduce Pulmonary Function Decline, Pulmonary Symptoms and Airway Hyperreactivity in Firefighters at the World Trade Center Site. Disaster Medicine and Public Health Preparedness 2008; 2:33-39.</li>
<li>Prezant DJ, Levin S, Kelly KJ, Aldrich TK.  Upper and Lower Respiratory Diseases after Occupational and Environmental Disasters.  Mt. Sinai Medical Journal (In Press).     </li>
</ol>
<p> </p>
Kenneth L. Pinsker
<p>Dr. Kenneth Pinsker is Professor Emeritus of Medicine at Einstein and an attending physician at Montefiore. He is the former Chief of the Pulmonary Service at the Moses Division and the former Director of the Pulmonary Intensive Care Unit. He is currently a preceptor in the Pulmonary Clinic and makes teaching rounds on the consultation service.</p>
<p><strong>Clinical Specialty Areas</strong></p>
<ul>
<li>pulmonary function</li>
<li>bronchoscopy</li>
<li>pleural disease</li>
<li>general pulmonary medicine</li>
</ul>
<p><strong>Academic and Research Interests </strong></p>
<ul>
<li>lung transplantation</li>
<li>tuberculosis</li>
<li>respiratory failure</li>
<li>World-Trade-Center-related pulmonary disease</li>
<li>history of pulmonary medicine</li>
</ul>
Denise J. Nunez
<p>My major area of interest is cardiac critical care.</p>
Victoire N. Ndong
Michel Nassar
Clinical interests include minimally invasive airway surgery and reconstruction, and the medical and surgical management of pediatric hearing loss, including endoscopic ear surgery, cochlear implants and bone anchored hearing aids (BAHA).<quillbot-extension-portal></quillbot-extension-portal>
In addition to his interests in the use of simulation in medical education, Dr. Nassar also has an interest in congenital cytomegalovirus (CMV) and hearing loss, including targeted CMV screening and the use of Valganciclovir for CMV-infected hearing-impaired infants (ValEAR).<quillbot-extension-portal></quillbot-extension-portal>
<p>Michel Nassar, MD, MSc, is Director, AeroDigestive Program at Children’s Hospital at Montefiore, and Co-Director, CranioFacial Clinic and Associate Professor of Otolaryngology at Montefiore-Einstein. Dr. Nassar takes a multidisciplinary approach to patients with complex aerodigestive disease. His clinical interests include minimally invasive airway surgery and reconstruction, and the medical and surgical management of pediatric hearing loss, including endoscopic ear surgery, cochlear implants and bone anchored hearing aids (BAHA). He also has expertise in the medical and surgical management of velopharyngeal disorders.</p><p>Dr. Nassar earned his medical degree at Saint Joseph University in Beirut, Lebanon in 2005. He began his postgraduate training in France, completing an otolaryngology residency at Hotel Dieu de France Hospital in 2010 and his Masters in Surgical Sciences and pediatric otolaryngology fellowship in 2012. He then came to the United States, completing a pediatric otolaryngology fellowship at Cincinnati Children’s Hospital in 2013.</p><p>In addition to his interests in the use of simulation in medical education, Dr. Nassar also has an interest in congenital cytomegalovirus (CMV) and hearing loss, including targeted CMV screening and the use of Valganciclovir for CMV-infected hearing-impaired infants (ValEAR). His work has been shared through peer-reviewed journals and oral presentations. He is also a reviewer for <em>Laryngoscope, the International Journal of Pediatric Otorhinolaryngology and the European Annals of Otorhinolaryngology</em>.</p><p>Dr. Nassar is a member of the American Academy of Otolaryngology–Head and Neck Surgery, the American Academy of Pediatrics and the International Federation of Oto-Rhino-Laryngological Societies. He has been listed among the <em>New York Times</em>’ Super Doctors - Rising Stars.</p>